WAYLAND, Mass. and LAKE FOREST, Calif., March 20, 2019 /PRNewswire/ -- Syneron Medical Ltd.
JAMA-Dermatology publishes Dr. Roy Geronemus' authored largest study of infants and babies receiving a non-invasive treatment (vs.
Following its recent CE mark, the first Vbeam Primas have arrived in Europe, the first in the UK is with leading dermatologist
New brand reflects commitment to Science, Results, T
Acquisition of Danish Ellipse adds globally renowned IPL and laser technologies to Candela’s portfolio, further strengthening their position in multi-application, multi-technology devices
The PicoWay® picosecond laser received U.S. Food and Drug Administration (FDA) clearance for a new ultra-short 785nm wavelength, which is the third FDA cleared wavelength for PicoWay.
Not all products are licensed in your country, please check with your local representative © 2019 Syneron ® Medical Ltd. All Right Reserved